NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Bluestem Biosciences, Inc.

Bluestem Biosciences, Inc.

Private
Omaha, NebraskaFrontier & Industrial Techhttps://www.bluestembiosciences.com/

Last Round

Grant

Oct 1, 2025

Total Funding Raised

$18.34M

Company Overview

Bluestem Biosciences, Inc. is a biotechnology company that develops a digital biology platform designed for the sustainable production of chemicals through proprietary anaerobic fermentation.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

renewable chemicalssynthetic biologysynbiobiomanufacturingbio-based acrylic acid3-hydroxypropionic acid3-HPfermentation technologyengineered yeastbioethanol plant retrofittechnology licensingcorn-to-chemicalsanaerobic fermentationprecision fermentationindustrial biotechnologywhite biotechgreen chemistrysustainable materialsdrop-in technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bluestem Biosciences, Inc. Comparables

Compare Bluestem Biosciences, Inc. with similar companies based on industry and business-model similarity.

Bluestem Biosciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Låkril Technologies
90%
ZymoChem
77%
Industrial Microbes
69%

Bluestem Biosciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2025
GrantJan 16, 2025
GrantSep 13, 2024
Pre SeedAug 9, 2022

Key People

Founding team and executive leadership

Tyler Autera

COO & Co-Founder

Founding Team

Billy Hagstrom

Chief Executive Officer Co-Founder

Founding Team

Bluestem Biosciences, Inc. Investors

Notable investors and investment history

Bluestem Biosciences, Inc. investors
InvestorRounds
Zero Infinity PartnersPre Seed
U.S. Department of WarGrant
Invest NebraskaPre Seed
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 15, 2024

    Monthly visitors grew 36% MoM, reaching 1.5K.

Bluestem Biosciences, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bluestem Biosciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bluestem Biosciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersOmaha, Nebraska
Employee Range11
Year Founded2022
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.